The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification

Overview of attention for article published in Experimental Hematology & Oncology, May 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 45 followers.

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification https://t.co/45H0OtKGAg https://t.co/WEiP4QycZk

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.